GlaxoSmithKline Balance Sheet
GlaxoSmithKline's total assets for Q4 2025 were £61.01B, a decrease of -26.12% from the previous quarter. GSK total liabilities were £45.02B for the fiscal quarter, a -26.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.